NRx Pharmaceuticals, Inc.

NASDAQ:NRXP

Biotechnology

Healthcare
$2.55 +1.43%

+$0.06 today

Market cap
$113.04M
Beta
2.19
P/E (TTM)
-5.3
EPS (TTM)
-$0.76
52W Low $1.62High $5.06

Volume 1.39M

Average 1.27M

Income Statement

Follow revenue through to earnings.

Revenue

$1.23M

FY 2025 · Annual

Operating Income

-$16.22M

FY 2025 · Annual

Net Income

-$28.62M

FY 2025 · Annual

Income Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Revenue00001.23M
Cost of Revenue2K4K5K5K505K
Gross Profit(2K)(4K)(5K)(5K)720K
Gross Margin————58.8%
Research & Development20.26M17.03M13.37M6.2M3.78M
Selling, General & Admin74.94M27.3M14.21M13.5M13.06M
Operating Expenses95.2M44.33M27.58M19.7M16.94M
Depreciation & Amortization2K4K5K5K143K
EBITDA(93.04M)(39.75M)(30.03M)(24.04M)(27.81M)
EBITDA Margin————-2270.0%
Operating Income(95.2M)(44.34M)(27.59M)(19.7M)(16.22M)
Operating Margin————-1324.4%
Interest Income18249K494K44K12K
Interest Expense18K0120K1.08M671K
Other Income / Expenses2.14M4.58M(2.56M)(5.42M)(12.4M)
Income Before Tax(93.06M)(39.75M)(30.15M)(25.13M)(28.62M)
Pre-Tax Margin————-2336.5%
Income Tax Expense00000
Net Income(93.06M)(39.75M)(30.15M)(25.13M)(28.62M)
Net Margin————-2336.5%
EPS (Basic)(7.44)(0.60)(3.98)(2.39)(1.34)
EPS (Diluted)(7.44)(0.60)(3.98)(2.39)(1.34)
Weighted Avg Shares46.92M65.77M7.58M10.52M21.4M
Weighted Avg Shares (Diluted)46.92M65.77M7.58M10.52M21.4M

NRXP Earnings Waterfall · TTM

NASDAQ:NRXP · Revenue to Net Income

Key Ratios

EPS$-1.28
Gross Margin29.2%
Net Margin-632.8%
P/E Ratio10.9
P/S Ratio113.8

Analysis

$2.3M of revenue converted into -$24.5M of net income for the selected period. Gross margin is 29.2% and net margin is -632.8%, showing how much revenue survives after costs and taxes. EPS is $-1.28, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
DEF 14ADEF 14A filingNov 5, 2026
DEFA14ADEFA14A filingNov 5, 2026
4Statement of changes in beneficial ownershipNov 4, 2026
4Statement of changes in beneficial ownershipNov 4, 2026
8-KCurrent reportNov 2, 2026

How much revenue does NRXP generate?

NRx Pharmaceuticals, Inc. (NRXP) reported $1.23M of revenue in fiscal 2025.

Is NRXP profitable?

NRx Pharmaceuticals, Inc. (NRXP) reported -$28.62M of net income, with a net margin of -2336.5%.